SEM — Select Medical Holdings Income Statement
0.000.00%
- $2.24bn
- $4.23bn
- $5.19bn
- 81
- 76
- 49
- 78
Annual income statement for Select Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,532 | 6,205 | 4,609 | 4,826 | 5,187 |
Cost of Revenue | |||||
Gross Profit | 821 | 919 | 401 | 572 | 634 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,952 | 5,489 | 4,464 | 4,573 | 4,948 |
Operating Profit | 580 | 716 | 145 | 253 | 239 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 456 | 630 | 35.3 | 140 | 175 |
Provision for Income Taxes | |||||
Net Income After Taxes | 345 | 500 | 18.5 | 110 | 130 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 259 | 402 | 159 | 243 | 214 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 250 | 389 | 160 | 241 | 212 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.33 | 2.97 | -0.116 | 0.557 | 0.679 |
Dividends per Share |